The Role of Hematological Inflammatory Biomarkers in the Diagnosis of Lung Cancer and in Predicting TNM Stage

Abstract

Objective

The aim of study is to investigate whether hematological inflammatory biomarkers could be useful to detect patients with lung cancer.

Methods

The contribution of hematological biomarkers to the diagnosis of lung cancer and prediction of TNM was examined.

Results

NLR, PLR, MPV values were found to be higher in patients with lung cancer (all p < .001). NLR and PLR were found to be high, MPV was found to be lower in disease of advanced stage (p < .001).

Conclusions

This study found that NLR, PLR and MPV values were significantly higher in patients with lung cancer.

Keywords:

• Diagnostic value
• lung cancer
• mean platelet volume
• neutrophil-to-lymphocyte ratio
• platelet-to-lymphocyte ratio

Declaration of interest

The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the article.